iRhythm Holdings, Inc. Common Stock
IRTC
$129.16
+6.96%
iRhythm Holdings is a digital healthcare company specializing in ambulatory cardiac monitoring devices and services. It is a leader in its niche, leveraging its proprietary Zio System to provide efficient arrhythmia diagnosis.
IRTC
iRhythm Holdings, Inc. Common Stock
$129.16
Investment Opinion: Should I buy IRTC Today?
Based on a synthesis of the data, the objective assessment is a Hold for risk-averse investors and a speculative Buy for aggressive growth investors with a high-risk tolerance. The company's strong fundamentals in revenue growth and cash flow are counterbalanced by poor profitability metrics and a precarious debt position. While analyst sentiment is positive and the stock is technically oversold, a definitive investment thesis requires clearer evidence of a path to consistent earnings. Investors should await more stable quarterly profitability before establishing a full position.
Sign up to view all
IRTC 12-Month Price Forecast
The outlook is bifurcated. The bull case is plausible given the oversold condition and growth, but the base case of volatile, range-bound action is most likely due to unresolved profitability and leverage issues. The high short interest adds potential for sharp moves in either direction.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on iRhythm Holdings, Inc. Common Stock's 12-month outlook, with a consensus price target around $167.91 and implied upside of +30.0% versus the current price.
Average Target
$167.91
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$103 - $168
Analyst target range
Wall Street analyst sentiment appears positive based on recent institutional ratings, with firms like Citigroup, Truist Securities, Baird, and Wells Fargo maintaining 'Buy' or 'Overweight' ratings as recently as February and March 2026. However, specific consensus target price data and ratings distribution are not provided in the inputs, limiting a detailed quantitative summary.
Bulls vs Bears: IRTC Investment Factors
IRTC presents a classic high-growth, high-risk profile. The company demonstrates strong top-line growth and cash generation but struggles with profitability and carries a heavy debt burden. The stock's sharp decline has priced in significant negativity, but a turnaround hinges on achieving sustainable profits.
Bullish
- Strong Revenue Growth: Q4 2025 revenue grew 27.1% YoY, indicating robust demand.
- Positive Free Cash Flow: Generated $34.5M TTM FCF, improving financial flexibility.
- High Gross Margin: Gross margin of 70.6% shows strong pricing power.
- Analyst Buy Ratings: Multiple institutions maintain positive ratings as of early 2026.
Bearish
- Lack of Consistent Profitability: Trailing EPS is negative, and ROE/ROA are deeply negative.
- High Debt Load: Debt-to-equity ratio of 4.79 indicates significant financial leverage.
- Elevated Valuation Multiples: PS ratio of 7.6 and forward PE of 136.6 are high.
- Severe Price Downtrend: Stock down 39% in 6 months, underperforming the market.
IRTC Technical Analysis
The stock has experienced a significant downtrend over the past six months, with the price falling from $187.30 on October 31, 2025, to $114.21 on March 30, 2026, representing a 39% decline. Short-term performance has been weak, with the stock down 14.6% over the past month and 36.0% over the past three months, significantly underperforming the broader market as indicated by the negative relative strength figures. The current price of $114.21 is near the lower end of its 52-week range of $92.52 to $212.00, suggesting the stock is in a technically oversold position relative to its recent high.
Beta
1.18
1.18x market volatility
Max Drawdown
-40.3%
Largest decline past year
52-Week Range
$106-$212
Price range past year
Annual Return
+20.8%
Cumulative gain past year
| Period | IRTC Return | S&P 500 |
|---|---|---|
| 1m | +9.4% | +10.5% |
| 3m | -16.4% | +3.9% |
| 6m | -31.0% | +5.4% |
| 1y | +20.8% | +29.6% |
| ytd | -26.3% | +5.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IRTC Fundamental Analysis
Revenue growth has been strong on a year-over-year basis, with Q4 2025 revenue of $208.89 million representing a 27.1% increase from the prior year. However, profitability has been inconsistent; while Q4 2025 showed a positive net income of $5.58 million, the trailing twelve-month EPS remains negative at -$0.0078. The company's financial health shows a high debt-to-equity ratio of 4.79, but it maintains a strong current ratio of 4.63 and generated positive free cash flow of $34.52 million over the trailing twelve months. Operational efficiency metrics are weak, with a negative Return on Equity of -29.2% and a negative Return on Assets of -2.4%, indicating challenges in generating profits from its equity and asset base.
Quarterly Revenue
$208890000.0B
2025-12
Revenue YoY Growth
+0.27%
YoY Comparison
Gross Margin
+0.70%
Latest Quarter
Free Cash Flow
$34521000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IRTC Overvalued?
Given the company's negative trailing net income, the Price-to-Sales (PS) ratio of 7.6 is the primary valuation metric used here. This ratio is based on a market capitalization of approximately $5.68 billion. The Enterprise Value-to-Sales (EV/Sales) ratio of 5.1 provides an alternative view that accounts for the company's debt and cash position. Data for a direct peer comparison of these sales-based multiples is not available in the provided inputs.
PE
-127.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -530x~256x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-1557.1x
Enterprise Value Multiple
Investment Risk Disclosure
The primary financial risk is IRTC's lack of consistent profitability, evidenced by negative trailing EPS and deeply negative returns on equity and assets. This raises questions about its business model's scalability and efficiency. The high debt-to-equity ratio of 4.79 amplifies financial risk, making the company vulnerable to rising interest rates or a downturn in cash flow. Market and sentiment risks are also elevated, with the stock in a severe downtrend, significant short interest, and a beta of 1.15 indicating higher volatility than the market. Operational risks include the challenge of transitioning strong revenue growth into sustained net income, as quarterly results have shown high variability. The high valuation multiples (PS of 7.6) leave little room for error, meaning any growth slowdown could lead to further multiple compression.
FAQ
The key risks are: 1) Profitability Risk: Persistent negative earnings and poor ROE/ROA. 2) Financial Risk: A high debt-to-equity ratio of 4.79 increases bankruptcy risk if cash flow falters. 3) Valuation Risk: High sales multiples could compress further if growth slows. 4) Market Risk: The stock is in a strong downtrend, has high short interest (ratio 3.91), and is more volatile than the market (beta 1.15).
The 12-month outlook is highly uncertain. The base case (50% probability) sees the stock trading between $115 and $160 as it consolidates. The bull case (30%) could see a rally to $160-$212 if profitability improves sharply. The bear case (20%) risks a fall to the $92-$110 range if operational challenges worsen. Analyst consensus is positive, but the stock's recent performance contradicts that sentiment.
Based on traditional metrics, IRTC appears overvalued. It trades at a high Price-to-Sales ratio of 7.6 and an extremely high forward P/E of 136.6, which are difficult to justify without imminent, massive profit expansion. The EV/Sales of 5.1 is slightly more reasonable. The stock is arguably undervalued relative to its growth potential, but it is overvalued relative to its current profitability profile.
IRTC is a speculative buy only for investors with a high risk tolerance and a long-term horizon. Its strong 27% revenue growth and positive free cash flow are positives, but its lack of consistent profits (negative EPS) and high debt (D/E of 4.79) are major red flags. The current price near its 52-week low may offer an entry point, but it requires a belief in the company's ability to achieve profitability soon.
IRTC is unsuitable for short-term trading due to its high volatility and negative momentum. It is only appropriate for a long-term (3-5+ year) investment horizon, where an investor can wait for the company to potentially resolve its profitability issues and realize its growth potential. The high short interest could cause sharp short-term rallies, but these are not a reliable basis for investment.
